Your browser does not support javascript! Please enable it, otherwise web will not work for you.

Ginkgo Bioworks engineers organisms for customers in biotech, pharma, agriculture, food, and materials using an automated “foundry” and a bio + AI data platform. It offers contract R&D, cloud lab services, and partnerships that can include licensing and royalties on resulting products. Founded in 2008 and headquartered in Boston, it is a public company listed on the NYSE and BMV.